Clinical Impact of the Initial Medication in Newly Diagnosed COPD Patients

분야: 의약학 > 내과학
저자: 이세원 , 김진희 , 김경주 , 김유리 , 유광하 , 윤형규 , 이진국 , 김영삼 , 오연목
발행기관: 대한결핵 및 호흡기학회
간행물정보: 대한결핵및호흡기학회 추계학술발표초록집 2012년, 제114권 197(총1페이지)
파일형식: 0y909902.pdf [무료 PDF 뷰어 다운로드]
※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
구매가격: 1,000원
적립금: 30원 (구매자료 3% 적립)

연관 논문

O-037 : Late Presentation of Hepatitis B among Patients with Newly Diagnosed Hepatocellular Carcinoma: A National Cohort Study

Original Articles : Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naive patients with chronic hepatitis Binfection

Original Article : The Effect of Early Insulin Therapy on Pancreatic β-Cell Function and Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients

응급질환 및 감시체계 : 당노병성 케톤산증에 대한 임상적 고찰 ( A Clinical Study on Diabetic Keteoacidosis )

O-092 : A Tool to Measure the Impact of Inaction towards Elimination of Hepatitis C: A Case Study in Korea

영문초록

The effect of long acting bronchodilators (LA-B) is well documented in various randomized controlled studies. However, it is not evident that this effect is still consistent in real practice. In this study, we analyzed the effect of LA-B for newly-diagnosed COPD patients. We analyzed Medicaid data from 2007 to 2010. Newly-diagnosed COPD patients were defined if the participants were ≥ 40 years old had never been registered as ``COPD`` (J42-44) for the past 2 years, then registered as COPD and prescribed COPD medication in 2009. LA-B group was defined if LA-B was prescribed ≥2 times in 2009. Short acting bronchodilator (SA-B) group was defined if LA-B was prescribed ＜2 times or only SA-B was prescribed. Oral medication (OM) group was defined if bronchodilator was never prescribed in 2009. A total of 77,800 patients were enrolled. 8,663 (71.5%) was male. Mean age was 66.0±10.5 years. LA-B group included 12,115, SA-B 5,173, and OM 60,192 patients. ER visit and hospitalization was associated with SA-B group, male, older age, Medicaid aid, Tertiary hospital utilization and more co-morbidity. ER visit, recurrent ER visit, hospitalization and recurrent hospitalization were increased in SA-B group in multivariate analysis (adjusted OR [95% confidence interval]=4.32 [3.93-4.75], 6.19 [5.24-7.30], 5.04 [2.95-3.39], 8.49 [7.67-9.39]) and it resulted in high medical cost. Long acting bronchodilator in initial medication showed lower hospitalization, ER visit and medical cost for newly-diagnosed COPD patients in real practice.

추천자료

[국제경영] 지멘스(Siemens AG) 전략(영문)

[[솔루션]] :: Lehninger Biochemistry 5edition[the foundations of Biochemistry]

[토익] 해커스 토익 예상문제(3년치분)

기출응용 레포트

[자료목록] 정부주도 경제개발체제

한국 OECD 교원정책 국제 세미나

[PBL] 전신부종과 호흡곤란을 호소한 젊은 여자

[토익] 토익 기출 단어 어휘 완전정복

스스로 미국 문학 개관 공부 하기태 동기와 독립 전후시대 문학

[의학과][응급의학과] 흉부외과 사례(77세 남성환자)

오늘 본 자료